Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stump

Showing results (1071-1080 of 1,095) with videos related to

Pageof 110
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Non-peptide alpha(v)beta(3) antagonists. Part 3: identification of potent RGD mimetics incorporating novel beta-amino acids as aspartic acid replacementsPaul J Coleman, Karen M Brashear, Cecilia A Hunt, et al.
Neuropharmacology|January 8, 2013
Mechanism based neurotoxicity of mGlu5 positive allosteric modulators--development challenges for a promising novel antipsychotic targetSophie Parmentier-Batteur, Peter H Hutson, Karsten Menzel, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2017
Discovery of MK-1832, a Kv1.5 inhibitor with improved selectivity and pharmacokineticsScott E Wolkenberg, M Brad Nolt, Mark T Bilodeau, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2006
Identification of novel, orally bioavailable spirohydantoin CGRP receptor antagonistsIan M Bell, Rodney A Bednar, John F Fay, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Orally efficacious NR2B-selective NMDA receptor antagonistsChristopher F Claiborne, John A McCauley, Brian E Libby, et al.
Virulence|May 19, 2022
Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19David J Gregory, Augustin Vannier, Akiro H Duey, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2024
Invention of novel 3-aminopiperidin-2-ones as calcitonin gene-related peptide receptor antagonistsDonnette D Staas, Ian M Bell, Christopher S Burgey, et al.
Journal of Medicinal Chemistry|May 2, 2003
Benzodiazepines as potent and selective bradykinin B1 antagonistsMichael R Wood, June J Kim, Wei Han, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2020
Identification of potent inhibitors of the sortilin-progranulin interactionShawn J Stachel, Anthony T Ginnetti, Scott A Johnson, et al.
Immunity|July 28, 2021
Resident cardiac macrophages mediate adaptive myocardial remodelingNicole R Wong, Jay Mohan, Benjamin J Kopecky, et al.
Pageof 110

Showing results (1071-1080 of 1,095) with videos related to

Sort By:
Pageof 110
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Non-peptide alpha(v)beta(3) antagonists. Part 3: identification of potent RGD mimetics incorporating novel beta-amino acids as aspartic acid replacementsPaul J Coleman, Karen M Brashear, Cecilia A Hunt, et al.
Neuropharmacology|January 8, 2013
Mechanism based neurotoxicity of mGlu5 positive allosteric modulators--development challenges for a promising novel antipsychotic targetSophie Parmentier-Batteur, Peter H Hutson, Karsten Menzel, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2017
Discovery of MK-1832, a Kv1.5 inhibitor with improved selectivity and pharmacokineticsScott E Wolkenberg, M Brad Nolt, Mark T Bilodeau, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2006
Identification of novel, orally bioavailable spirohydantoin CGRP receptor antagonistsIan M Bell, Rodney A Bednar, John F Fay, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Orally efficacious NR2B-selective NMDA receptor antagonistsChristopher F Claiborne, John A McCauley, Brian E Libby, et al.
Virulence|May 19, 2022
Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19David J Gregory, Augustin Vannier, Akiro H Duey, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2024
Invention of novel 3-aminopiperidin-2-ones as calcitonin gene-related peptide receptor antagonistsDonnette D Staas, Ian M Bell, Christopher S Burgey, et al.
Journal of Medicinal Chemistry|May 2, 2003
Benzodiazepines as potent and selective bradykinin B1 antagonistsMichael R Wood, June J Kim, Wei Han, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2020
Identification of potent inhibitors of the sortilin-progranulin interactionShawn J Stachel, Anthony T Ginnetti, Scott A Johnson, et al.
Immunity|July 28, 2021
Resident cardiac macrophages mediate adaptive myocardial remodelingNicole R Wong, Jay Mohan, Benjamin J Kopecky, et al.
Pageof 110